Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Sarcoma 1Plasma cell 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 75Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 59Lymphoma, Non-Hodgkin 57Hodgkin Disease 55Multiple Myeloma 54Myelodysplastic Syndromes 52Leukemia 45Lymphoma, Mantle-Cell 42Lymphoma, Follicular 39Lymphoma, Large B-Cell, Diffuse 36Lymphoma 36Lymphoma, B-Cell, Marginal Zone 35Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35Myeloproliferative Disorders 32Leukemia, Myelomonocytic, Chronic 31Burkitt Lymphoma 31Congenital Abnormalities 28Lymphoma, Large-Cell, Immunoblastic 27Waldenstrom Macroglobulinemia 26Leukemia, Myeloid, Chronic-Phase 25Leukemia, Myeloid, Accelerated Phase 23Lymphoma, T-Cell, Cutaneous 21Recurrence 20Primary Myelofibrosis 20Lymphoma, Large-Cell, Anaplastic 19Dendritic Cell Sarcoma, Interdigitating 19Hematologic Neoplasms 18Blast Crisis 18Anemia, Refractory, with Excess of Blasts 18

Interventions

fludarabine phosphate 3Antilymphocyte Serum 3Whole-Body Irradiation 2Cyclophosphamide 2treosulfan 1thymoglobulin 1posaconazole 1fludarabine 1X-Rays 1Thiotepa 1Tacrolimus 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Busulfan 1Bone Marrow Transplantation 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Bone Marrow Failure Disorders × Whole-Body Irradiation × Clear all
NCT02722668 2025-07-04

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
15 enrolled 15 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Bone Marrow Failure Disorders, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Plasma Cell, Lymphoma, Follicular, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡